☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Combivent discontinuation announced

The manufacturer of Combivent® (ipratropium 20micrograms / salbutamol 100micrograms) has announced that the metered dose aerosol inhaler will be discontinued in 2008.

The decision to discontinue this product is based upon European CFC environmental legislation that restricts the use of CFC propellants. There are no concerns about the safety profile, effectiveness or quality of the product.

This product is indicated in the British National Formulary as being less suitable for prescribing.

Action: Clinicians should take this opportunity to review existing treatments. Prescription of ipratropium and salbutamol in separate inhalers is one solution to this discontinuation.

Share 'Combivent discontinuation announced' by emailShare 'Combivent discontinuation announced' on FacebookShare 'Combivent discontinuation announced' on TwitterShare 'Combivent discontinuation announced' on LinkedInShare 'Combivent discontinuation announced' on reddit


No Comments to “Combivent discontinuation announced”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.